4.7 Article

Decreased central μ-opioid receptor availability in fibromyalgia

Journal

JOURNAL OF NEUROSCIENCE
Volume 27, Issue 37, Pages 10000-10006

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2849-07.2007

Keywords

fibromyalgia; opioid; pain; chronic; positron emission tomography; mu

Categories

Funding

  1. NCCIH NIH HHS [K01 AT001111, R01 AT 001415, K01 AT01111-01, R01 AT001415] Funding Source: Medline
  2. NCRR NIH HHS [K12 RR017607-01, M01-RR000042, M01 RR000042, K12 RR017607] Funding Source: Medline

Ask authors/readers for more resources

The underlying neurophysiology of acute pain is fairly well characterized, whereas the central mechanisms operative in chronic pain states are less well understood. Fibromyalgia (FM), a common chronic pain condition characterized by widespread pain, is thought to originate largely from altered central neurotransmission. We compare a sample of 17 FM patients and 17 age- and sex-matched healthy controls, using mu-opioid receptor (MOR) positron emission tomography. We demonstrate that FM patients display reduced MOR binding potential (BP) within several regions known to play a role in pain modulation, including the nucleus accumbens, the amygdala, and the dorsal cingulate. MOR BP in the accumbens of FM patients was negatively correlated with affective pain ratings. Moreover, MOR BP throughout the cingulate and the striatum was also negatively correlated with the relative amount of affective pain (McGill, affective score/sensory score) within these patients. These findings indicate altered endogenous opioid analgesic activity in FM and suggest a possible reason for why exogenous opiates appear to have reduced efficacy in this population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available